Skip to Main Content

Paper Details

Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.
Cancer Discov
250
2019
Author NameAffiliation
Saurabh AsthanaHelen Diller Family Comprehensive Cancer Center, University of California san francisco
Saurabh AsthanaHelen Diller Family Comprehensive Cancer Center, University of California san francisco
Elisabeth A LasaterUniversity of California san francisco
Elisabeth A LasaterInc.
Neil P ShahUniversity of California san francisco
Neil P ShahHelen Diller Family Comprehensive Cancer Center, University of California san francisco
Catherine C SmithUniversity of California san francisco
Catherine C SmithHelen Diller Family Comprehensive Cancer Center, University of California san francisco
  • 1 - 8

Datasets

Release 1.2